FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013089450> ?p ?o ?g. }

• W2013089450 endingPage "151" @default.
• W2013089450 startingPage "145" @default.
• W2013089450 abstract "We assessed whether patients with bipolar disorder received serum drug level and toxicity monitoring for mood stabilizers and assessment of cardiovascular disease (CVD)-related risk factors attributed to atypical antipsychotic medications.A population-based study of individuals with bipolar disorder was conducted between July 2004 and July 2006. Based on American Psychiatric and American Diabetes Association guidelines, we assessed whether patients received recommended drug level and toxicity monitoring tests on or within 6 months for mood stabilizers, and lipid and glucose tests for atypical antipsychotics. Multivariable regression was used to determine the patient factors associated with receipt of lab tests.Of the 435 patients (mean age=49 years, 14.3% female, 22.8% nonwhite), 60.3% were currently prescribed mood stabilizers and 65.5% were prescribed atypical antipsychotics. Overall, 39.7% received a serum drug level for mood stabilizers, 38.8% received a thyroid function test for lithium, and the majority (71.4%-75.9%) received complete blood counts and hepatic function tests for valproate or carbamazepine. About half of patients prescribed atypical antipsychotics received cholesterol counts (49.6%), and 68.7% received serum glucose levels. After adjusting for patient factors, women prescribed atypical antipsychotics were less likely than men to receive cholesterol counts (OR=0.43; p<0.05).Single-site retrospective study and a relatively short observation period.About half of patients received recommended lab tests for mood stabilizers and atypical antipsychotics. Additional research regarding whether the receipt of these lab tests is associated with improved outcomes will inform efforts to improve quality of care related to drug toxicities and CVD risk factors in patients with bipolar disorder." @default.
• W2013089450 created "2016-06-24" @default.
• W2013089450 creator A5012227398 @default.
• W2013089450 creator A5028964025 @default.
• W2013089450 creator A5041963458 @default.
• W2013089450 creator A5048988655 @default.
• W2013089450 creator A5063361131 @default.
• W2013089450 creator A5074657092 @default.
• W2013089450 creator A5085060315 @default.
• W2013089450 date "2007-09-01" @default.
• W2013089450 modified "2023-10-14" @default.
• W2013089450 title "Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder" @default.
• W2013089450 cites W1965773916 @default.
• W2013089450 cites W1978179922 @default.
• W2013089450 cites W1983339571 @default.
• W2013089450 cites W1997942337 @default.
• W2013089450 cites W2013453964 @default.
• W2013089450 cites W2013890548 @default.
• W2013089450 cites W2022389996 @default.
• W2013089450 cites W2033741577 @default.
• W2013089450 cites W2034697959 @default.
• W2013089450 cites W2052670093 @default.
• W2013089450 cites W2062664316 @default.
• W2013089450 cites W2065604182 @default.
• W2013089450 cites W2075977735 @default.
• W2013089450 cites W2076608111 @default.
• W2013089450 cites W2091996033 @default.
• W2013089450 cites W2098234705 @default.
• W2013089450 cites W2113823824 @default.
• W2013089450 cites W2147803573 @default.
• W2013089450 cites W2163303198 @default.
• W2013089450 cites W2163776898 @default.
• W2013089450 cites W2164108512 @default.
• W2013089450 cites W2164431067 @default.
• W2013089450 cites W2165760812 @default.
• W2013089450 cites W2170351165 @default.
• W2013089450 cites W4232541108 @default.
• W2013089450 doi "https://doi.org/10.1016/j.jad.2007.01.006" @default.
• W2013089450 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17276514" @default.
• W2013089450 hasPublicationYear "2007" @default.
• W2013089450 type Work @default.
• W2013089450 sameAs 2013089450 @default.
• W2013089450 citedByCount "66" @default.
• W2013089450 countsByYear W20130894502012 @default.
• W2013089450 countsByYear W20130894502013 @default.
• W2013089450 countsByYear W20130894502014 @default.
• W2013089450 countsByYear W20130894502015 @default.
• W2013089450 countsByYear W20130894502016 @default.
• W2013089450 countsByYear W20130894502017 @default.
• W2013089450 countsByYear W20130894502018 @default.
• W2013089450 countsByYear W20130894502019 @default.
• W2013089450 countsByYear W20130894502020 @default.
• W2013089450 countsByYear W20130894502021 @default.
• W2013089450 countsByYear W20130894502023 @default.
• W2013089450 crossrefType "journal-article" @default.
• W2013089450 hasAuthorship W2013089450A5012227398 @default.
• W2013089450 hasAuthorship W2013089450A5028964025 @default.
• W2013089450 hasAuthorship W2013089450A5041963458 @default.
• W2013089450 hasAuthorship W2013089450A5048988655 @default.
• W2013089450 hasAuthorship W2013089450A5063361131 @default.
• W2013089450 hasAuthorship W2013089450A5074657092 @default.
• W2013089450 hasAuthorship W2013089450A5085060315 @default.
• W2013089450 hasConcept C118552586 @default.
• W2013089450 hasConcept C126322002 @default.
• W2013089450 hasConcept C2776174506 @default.
• W2013089450 hasConcept C2776412080 @default.
• W2013089450 hasConcept C2776921671 @default.
• W2013089450 hasConcept C2777134132 @default.
• W2013089450 hasConcept C2778186239 @default.
• W2013089450 hasConcept C2779253243 @default.
• W2013089450 hasConcept C2780494398 @default.
• W2013089450 hasConcept C2780550438 @default.
• W2013089450 hasConcept C2780733359 @default.
• W2013089450 hasConcept C2908647359 @default.
• W2013089450 hasConcept C558461103 @default.
• W2013089450 hasConcept C71924100 @default.
• W2013089450 hasConcept C99454951 @default.
• W2013089450 hasConceptScore W2013089450C118552586 @default.
• W2013089450 hasConceptScore W2013089450C126322002 @default.
• W2013089450 hasConceptScore W2013089450C2776174506 @default.
• W2013089450 hasConceptScore W2013089450C2776412080 @default.
• W2013089450 hasConceptScore W2013089450C2776921671 @default.
• W2013089450 hasConceptScore W2013089450C2777134132 @default.
• W2013089450 hasConceptScore W2013089450C2778186239 @default.
• W2013089450 hasConceptScore W2013089450C2779253243 @default.
• W2013089450 hasConceptScore W2013089450C2780494398 @default.
• W2013089450 hasConceptScore W2013089450C2780550438 @default.
• W2013089450 hasConceptScore W2013089450C2780733359 @default.
• W2013089450 hasConceptScore W2013089450C2908647359 @default.
• W2013089450 hasConceptScore W2013089450C558461103 @default.
• W2013089450 hasConceptScore W2013089450C71924100 @default.
• W2013089450 hasConceptScore W2013089450C99454951 @default.
• W2013089450 hasIssue "1-3" @default.
• W2013089450 hasLocation W20130894501 @default.
• W2013089450 hasLocation W20130894502 @default.
• W2013089450 hasOpenAccess W2013089450 @default.
• W2013089450 hasPrimaryLocation W20130894501 @default.
• W2013089450 hasRelatedWork W1761357618 @default.

• next